Polar Capital LLP - Q3 2020 holdings

$13.5 Billion is the total value of Polar Capital LLP's 298 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was - .

 Value Shares↓ Weighting
MTCH NewMATCH GROUP INC NEW$86,821,000784,643
+100.0%
0.64%
CHGG NewCHEGG INC$85,007,0001,189,909
+100.0%
0.63%
ZBH NewZIMMER BIOMET HOLDINGS INC$58,560,000430,142
+100.0%
0.44%
AVLR NewAVALARA INC$53,488,000420,038
+100.0%
0.40%
SHOP NewSHOPIFY INCcl a$49,966,00048,844
+100.0%
0.37%
TWOU New2U INC$45,901,0001,355,606
+100.0%
0.34%
CCXI NewCHEMOCENTRYX INC$44,319,000808,739
+100.0%
0.33%
MOH NewMOLINA HEALTHCARE INC$39,500,000215,800
+100.0%
0.29%
STE NewSTERIS PLC$38,483,000218,415
+100.0%
0.29%
MMSI NewMERIT MED SYS INC$29,938,000688,231
+100.0%
0.22%
ALC NewALCON AG$26,581,000485,237
+100.0%
0.20%
IAC NewIAC INTERACTIVECORP NEW$21,407,000178,722
+100.0%
0.16%
NewAKAMAI TECHNOLOGIES INCnote 0.375% 9/0$20,246,00017,500,000
+100.0%
0.15%
LLY NewLILLY ELI & CO$18,947,000128,000
+100.0%
0.14%
NewSOUTHWEST AIRLS COnote 1.250% 5/0$18,923,00014,500,000
+100.0%
0.14%
CLDX NewCELLDEX THERAPEUTICS INC NEW$18,538,0001,250,000
+100.0%
0.14%
SMMT NewSUMMIT THERAPEUTICS INC$17,200,0005,000,000
+100.0%
0.13%
NewSNAP INCnote 0.750% 8/0$16,613,00012,000,000
+100.0%
0.12%
DG NewDOLLAR GEN CORP NEW$16,382,00078,150
+100.0%
0.12%
SGRY NewSURGERY PARTNERS INC$16,136,000736,792
+100.0%
0.12%
ORCL NewORACLE CORP$16,178,000270,980
+100.0%
0.12%
KURA NewKURA ONCOLOGY INC$15,320,000500,000
+100.0%
0.11%
RAMP NewLIVERAMP HLDGS INC$13,436,000259,539
+100.0%
0.10%
NewCHINA LODGING GROUP LTDnote 0.375%11/0$11,261,00010,000,000
+100.0%
0.08%
PRSC NewPROVIDENCE SVC CORP$11,082,000119,276
+100.0%
0.08%
COUP NewCOUPA SOFTWARE INC$10,560,00038,506
+100.0%
0.08%
FWONK NewLIBERTY MEDIA CORP DEL$10,515,000289,903
+100.0%
0.08%
NewEXACT SCIENCES CORPnote 0.375% 3/0$9,718,0009,000,000
+100.0%
0.07%
MXL NewMAXLINEAR INC$9,670,000416,095
+100.0%
0.07%
ZNTL NewZENTALIS PHARMACEUTICALS INC$8,826,000270,000
+100.0%
0.07%
HGEN NewHUMANIGEN INC$8,778,000825,000
+100.0%
0.06%
CTLT NewCATALENT INC$7,396,00086,345
+100.0%
0.06%
CRDF NewCARDIFF ONCOLOGY INC$6,711,000472,908
+100.0%
0.05%
NewTWITTER INCnote 0.250% 6/1$6,694,0006,000,000
+100.0%
0.05%
VRNA NewVERONA PHARMA PLCsponsored ads$6,240,0001,000,000
+100.0%
0.05%
UMRX NewUNUM THERAPEUTICS INC$5,850,0002,500,000
+100.0%
0.04%
TSM NewTAIWAN SEMICONDUCTOR MFG LTDsponsored ads$4,900,00060,446
+100.0%
0.04%
PM NewPHILIP MORRIS INTL INC$4,649,00062,000
+100.0%
0.04%
SQ NewSQUARE INCcl a$4,527,00027,848
+100.0%
0.03%
ITCI NewINTRA CELLULAR THERAPIES INC$3,849,000150,000
+100.0%
0.03%
LH NewLABORATORY CORP AMER HLDGS$3,784,00020,100
+100.0%
0.03%
QGEN NewQIAGEN NV$3,377,00060,000
+100.0%
0.02%
NewAERIE PHARMACEUTICALS INCnote 1.500%10/0$2,931,0003,675,000
+100.0%
0.02%
VERX NewVERTEX INCcl a$2,783,000121,000
+100.0%
0.02%
PTCT NewPTC THERAPEUTICS INC$2,338,00050,000
+100.0%
0.02%
ORLY NewOREILLY AUTOMOTIVE INC$2,259,0004,900
+100.0%
0.02%
AEM NewAGNICO EAGLE MINES LTD$2,234,00023,670
+100.0%
0.02%
GOLD NewBARRICK GOLD CORP$2,149,00064,421
+100.0%
0.02%
API NewAGORA INCads$2,064,00048,015
+100.0%
0.02%
GD NewGENERAL DYNAMICS CORP$1,620,00011,700
+100.0%
0.01%
RNLX NewRENALYTIX AI PLCads$1,219,000100,000
+100.0%
0.01%
NewGOSSAMER BIO INCnote 5.000% 6/0$1,031,0001,000,000
+100.0%
0.01%
EEFT NewEURONET WORLDWIDE INC$957,00010,500
+100.0%
0.01%
NewAMERICAN AIRLS GROUP INCnote 6.500% 7/0$927,0001,000,000
+100.0%
0.01%
BSY NewBENTLEY SYS INC$785,00025,000
+100.0%
0.01%
PNTG NewPENNANT GROUP INC$605,00015,700
+100.0%
0.00%
NewPINDUODUO INCnote 10/0$456,000250,000
+100.0%
0.00%
BRKR NewBRUKER CORP$224,0005,632
+100.0%
0.00%
VCEL NewVERICEL CORP$206,00011,108
+100.0%
0.00%
CNMD NewCONMED CORP$234,0002,974
+100.0%
0.00%
BABA NewALIBABA GROUP HLDG LTDcall$206,000700
+100.0%
0.00%
GNMK NewGENMARK DIAGNOSTICS INC$158,00011,100
+100.0%
0.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-11-16
  • View 13F-HR/A filed 2020-11-17
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
APPLE INC30Q3 20205.1%
MICROSOFT CORP30Q3 20205.9%
FACEBOOK INC30Q3 20204.2%
Arch Capital Group30Q3 20202.6%
AMAZON COM INC30Q3 20203.3%
VISA INC30Q3 20201.8%
MARKEL CORP30Q3 20201.8%
BERKSHIRE HATHAWAY INC DEL30Q3 20201.8%
MARSH & MCLENNAN COS INC30Q3 20201.8%
JPMORGAN CHASE & CO30Q3 20201.8%

View Polar Capital LLP's complete holdings history.

Latest significant ownerships (13-D/G)
Polar Capital LLP Q3 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
BELLUS Health Inc.February 14, 20203,023,6255.5%
Dermira, Inc.February 14, 20202,841,5405.2%
Oxford Immunotec Global PLCFebruary 14, 20202,568,3859.7%
Quotient LtdFebruary 14, 20207,257,3199.0%
AVEO PHARMACEUTICALS INCSold outFebruary 14, 201900.0%
Heritage Insurance Holdings, Inc.February 14, 20191,278,5004.8%
STEMLINE THERAPEUTICS INCFebruary 14, 20192,902,6669.1%
Achaogen IncFebruary 14, 20181,881,3804.4%
MERU NETWORKS INCFebruary 10, 20121,032,0045.9%

View Polar Capital LLP's complete significant-ownership history.

Latest filings
TypeFiled
13F-NT2024-04-04
13F-NT2023-11-14
13F-NT2023-08-14
13F-NT2023-05-15
13F-NT2023-02-14
13F-NT2022-11-14
13F-NT2022-08-15
13F-NT2022-05-16
13F-NT2022-02-14
13F-NT2021-11-15

View Polar Capital LLP's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been amended

Export Polar Capital LLP's holdings